Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes.

cause it potentially affects the duration of patient isolation. The duration of colonization may impact patient-to-patient transmission during the index hospitalization in which patients with ESBL-producing E. coli and K. pneumoniae colonization were identified, as well as patient-to-patient transmission during future hospitalizations [6]. The significant association between outpatient antibiotic exposure and prolonged duration of stool colonization suggests the need for ongoing antimicrobial stewardship to help in limiting the emergence of hospitaland community-associated infections due to ESBLproducing microorganisms.

[1]  J. Raboud,et al.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Sung,et al.  Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  F. Hayden,et al.  John F. Enders lecture 2006: antivirals for influenza. , 2007, The Journal of infectious diseases.

[4]  J. Sung,et al.  Factors Associated with Early Hospital Discharge of Adult Influenza Patients , 2007, Antiviral therapy.

[5]  M. D. de Jong,et al.  Neuraminidase Inhibitors and their Role in Avian and Pandemic Influenza , 2005, Antiviral therapy.

[6]  Jessina C. McGregor,et al.  What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.